Pharmaceutical Business review

Sherpa opens new CGMP production facility in San Diego

The new facility houses five controlled access and monitored packaging suites, and walk-in 2-8 degrees C and -20 degrees C storage areas.

The company has also installed alarms, on site emergency back up generator power extra refrigeration systems for minimizing the risks linked with cold storage.

Sherpa president Mark Paiz said they purpose-built the facility to accommodate the needs of pharmaceutical and biotech clients that require controlled environments for their clinical study materials.

"The site offers companies conducting clinical studies an option to label, package, store, and distribute on the West Coast, which is particularly important for many biotechnology companies whose products require cold storage," Paiz said.